Polypoidal Choroidal Vasculopathy: Clinical Trials

1 trial for Polypoidal Choroidal Vasculopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1
Phase 21Unknown 1

Follow Polypoidal Choroidal Vasculopathy: new trials by email Literature Review of Polypoidal Choroidal Vasculopathy trials Research Report on Polypoidal Choroidal Vasculopathy

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety Study of High-Dose Ranibizumab for Polypoidal Choroidal Vasculopathy
ranibizumab 2.0mg - Polypoidal Choroidal Vasculopathy
Phase 1 / Phase 2UnknownRetina Consultants of Hawaii202010-11-012010-11-25

Narrower conditions

Vascular Diseases (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Choroid Diseases (1)  ·  Choroidal Neovascularization (1)  ·  Eye Diseases (1)  ·  Metaplasia (1)  ·  Neovascularization, Pathologic (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Uveal Diseases (1)

Interventions

Ranibizumab (1)

Sponsors

Retina Consultants of Hawaii (1)

Countries

United States (1)

Top investigators

Gregg T Kokame, MD, MMM (1)